Treating Non-cystic Fibrosis Bronchiectasis with CFTR modulators: Early Case Reports [PDF]
Colin E Swenson +11 more
openalex +1 more source
Mouse cholangiocytes are isolated from bile ducts and cultured in conditioned medium containing ROCK inhibitor. Cells maintain expression of biliary markers & ion channel activity for >50 passages. Abstract Cultures of primary mouse bile duct epithelial cells are a valuable tool to study cholangiocyte secretion and bile formation.
Qin Li +4 more
wiley +1 more source
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis, largely because of late‐stage diagnosis and therapeutic resistance. PDAC incidence has been rising, with modifiable and non‐modifiable risk factors contributing to disease development.
Alessandro Mannucci, Ajay Goel
wiley +1 more source
Long-Term Follow-Up of Health-Related Quality of Life and Short-Term Intervention with CFTR Modulator Therapy in Adults with Cystic Fibrosis: Evaluation of Changes over Several Years with or without 33 Weeks of CFTR Modulator Therapy. [PDF]
Gruber W +10 more
europepmc +1 more source
Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages [PDF]
Jonathan L. Gillan +2 more
openalex +1 more source
WS14.02 Cystic fibrosis personalised medicine; paediatric in vitro airway cell models to predict CFTR modulator patient outcomes [PDF]
Laura K. Fawcett +2 more
openalex +1 more source
The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis. [PDF]
Mehta AM +8 more
europepmc +1 more source
Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy [PDF]
Tatiana Yuzyuk +7 more
openalex +1 more source

